Content provided in partnership with
Technology Industry
Industry: Email Alert RSS FeedPlasma Science LLC
BT Catalyst, Jan, 2000
The Consortium for Plasma Science LLC of Charlotte and Boston Biomedica Inc. (Nasdaq: BBII) of West Bridgewater, Mass., have agreed to collaborate on the development and commercialization of BBI's proprietary Pressure Cycling Technology for the inactivation of pathogens and other infectious agents in human plasma.
- Most Popular Articles in Technology
- An overview of continuous data protection
- Why all those current ratings?
- Many countries now have a mobile penetration rate above 100%, report says
- The Tata Group's big telecom gamble: VSNL's recent acquisition of Tyco ...
- MEASURING BANK BRANCH EFFICIENCY USING DATA ENVELOPMENT ANALYSIS: MANAGERIAL ...
- More »
The Consortium will provide initial funding to cover BBI's research efforts, with subsequent funding contemplated during the first half of 2000, and annually thereafter, based on the achievement of milestones. The Consortium will receive royalties on future product sales.
COPYRIGHT 2000 North Carolina Biotechnology Center
COPYRIGHT 2008 Gale, Cengage Learning
Find Research Guides for:
Find Featured Titles for: Health
- AAACN Viewpoint
- ABNF Journal, The
- AIDS Treatment News
- AMAA Journal
- Aboriginal Nurse, The
- Adolescence
- Adolescent Psychiatry
- Advances in Skin & Wound Care
- Age and Ageing
- Alabama Nurse
- Alberta RN
- Alcohol Research & Health
- Alternative Medicine Review
- American Family Physician
- American Fitness
- Men's Fitness
- Psychology Today
- Shape
Most Popular Articles in Technology
- An overview of continuous data protection
- Why all those current ratings?
- Many countries now have a mobile penetration rate above 100%, report says
- The Tata Group's big telecom gamble: VSNL's recent acquisition of Tyco ...
- MEASURING BANK BRANCH EFFICIENCY USING DATA ENVELOPMENT ANALYSIS: MANAGERIAL ...
- More »